Post-approval commitment for HSA-2023-0072. Category: Pharmacovigilance. Priority: high.

Commitment ID
COM-272
Application
Authority
Health Sciences Authority
Category
Pharmacovigilance
Priority
high
Status
In Progress
Due Date
2025-09-15
Completed At
—
Owner
Dmitri Volkov
Created
2023-02-20
Description

Provide confirmatory bioequivalence study for 200 mg strength

Evidence (0)
No evidence documents attached. Upload evidence to mark this commitment as complete.